THE CODI Co.,LTD. (KOSDAQ:224060)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,240.00
+140.00 (4.52%)
At close: Jan 23, 2026
-17.03%
Market Cap16.63B
Revenue (ttm)33.17B
Net Income (ttm)-5.40B
Shares Out5.13M
EPS (ttm)-1,065.89
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume23,198
Average Volume180,779
Open3,180.00
Previous Close3,100.00
Day's Range3,140.00 - 3,250.00
52-Week Range2,400.00 - 4,245.00
Beta0.17
RSI59.89
Earnings DateMar 20, 2026

About THE CODI Co.,LTD.

THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agent for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. The company was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD. was founded in 1999 and is headquartered in Cheonan-si, South Korea. [Read more]

Industry Special Industry Machinery, not elsewhere classified
Founded 1999
Employees 39
Stock Exchange KOSDAQ
Ticker Symbol 224060
Full Company Profile

Financial Performance

In 2024, THE CODI Co.,LTD.'s revenue was 33.52 billion, an increase of 65.82% compared to the previous year's 20.21 billion. Losses were -3.48 billion, -56.34% less than in 2023.

Financial Statements